GLP-1 regrets: what the science says about side effects and muscle loss

What did @latricia_nicole actually say?

She said the one thing she regrets about her GLP-1 journey is "not exercising properly" and "definitely not doing enough weight training." Her doctor warned her at the time of prescribing that skipping resistance training would lead to muscle loss. She went to the gym maybe five times since January, life intervened, and she now believes she has lost significant muscle mass. She is heading back to her doctor for a body composition check before starting maintenance dosing.

This is a personal experience video, not a medical advice video. She is not claiming a cure, not dosing anyone, not selling anything. She is sharing a genuine regret with transparency. That matters when evaluating tone. The core claim is: GLP-1s combined with insufficient resistance training leads to meaningful muscle mass loss. That claim deserves a real look.

Does the science back this up?

Yes, and pretty strongly. This is one of the more well-supported concerns in the GLP-1 literature right now, and her doctor gave her accurate guidance.

A 2021 trial published in The New England Journal of Medicine (Wilding et al.) showed semaglutide users lost an average of 14.9% of body weight over 68 weeks. The problem: studies consistently show that roughly 25-40% of weight lost on GLP-1 receptor agonists can come from lean mass, not fat, when exercise is absent. A 2023 analysis in Obesity Reviews (Bellicha et al.) found that without structured resistance training, GLP-1-driven weight loss accelerates lean mass reduction beyond what you'd expect from diet alone. Tirzepatide data from the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed similar total weight loss but did not isolate muscle preservation outcomes in the main analysis.

The mechanism is not mysterious. GLP-1s suppress appetite aggressively. If you are eating significantly less and not providing a resistance training stimulus, your body has no reason to preserve muscle tissue. The "use it or lose it" principle applies here more than usual because the caloric deficit is often steeper than people realize.

What did they get wrong (or right)?

She got the core message right. Her doctor got it right too. Resistance training is the primary tool for preserving lean mass during a significant caloric deficit, and GLP-1-induced deficits can be steep.

One thing worth flagging: she says she does not know how much muscle she has lost because she has not had a follow-up body composition scan yet. That is honest, but it also means the severity of her loss is unverified. The scale she references, likely a bioelectrical impedance analysis (BIA) device, has real limitations. BIA accuracy can fluctuate with hydration, and it is not the gold standard. DEXA scanning is more reliable for tracking lean mass changes over time.

She also mentions cardio and resistance training almost interchangeably at first, then correctly separates them. For muscle preservation specifically, resistance training is the primary tool. Cardio supports cardiovascular health and energy expenditure but does not provide the same anabolic stimulus. Her doctor apparently emphasized both, which is reasonable general advice, but the framing matters if people walk away thinking a few treadmill sessions is sufficient.

What should you actually know?

If you are on a GLP-1 medication and not doing resistance training, this video is a useful warning. Here is what the evidence actually supports:

• Resistance training two to three times per week has been shown in multiple trials to meaningfully preserve lean mass during weight loss interventions.
• Protein intake matters alongside exercise. A 2022 paper in Nutrients (Carbone and Pasiakos) found that higher protein intake combined with resistance training was the most effective strategy for preserving muscle during caloric restriction.
• BIA scans, like the one she mentions, can detect trends over time but should not be treated as precise measurements. DEXA is the more reliable option if you want accurate baseline data.
• Muscle loss is not permanent for most people. Progressive resistance training can rebuild lean mass even after a period of inactivity, though recovery takes consistent effort over months.
• GLP-1 medications are not inherently muscle-wasting drugs. The muscle loss risk is largely a function of how large the caloric deficit is and whether resistance training offsets it.

Her message is practical and accurate. The regret is legitimate, and the advice she is implicitly giving, start resistance training before or at the beginning of your GLP-1 journey, is well-supported.